The importance of viral protein-2 (VP2) of canine parvovirus (CPV) in binding to human cancer cells, production of veterinary vaccines and diagnostic kits has motivated several researches on producing this protein. Objectives: Our purpose was to construct recombinant bacmid shuttle vectors expressing VP2 of CPV using Bac-to-Bac baculoviral expression system. Materials and Methods: Mini-Tn7 transposones engineered in pFastBac1 donor vectors were used to construct expression cassettes of GFP and CPV-VP2. The plasmids were transferred into E. coli DH 10 Bac competent cells. Site-specifi c transposition of the genes into bacmid was accomplished using helper plasmid. Occurrence of Transposition was confi rmed via PCR using specifi c primers and PUC/M 13 universal primers. The recombinant bacmid DNAs were transfected into Sf9 cells using cationic lipids to generate new recombinant baculoviruses expressing GFP and CPV-VP2. GFP and VP2 expressions were evaluated by fl uorescence microscopy and western analysis, respectively. Results: Cloning, subcloning and recombination processes of both GFP and VP2 were accomplished and verifi ed. Accuracy of transfection process was confi rmed by GFP fl uorescence microscopy.VP2 expression was verifi ed by SDS-PAGE and western analysis. Conclusions: Two Bac-to-Bac expression systems were designed to produce recombinant VP2 and GFP in insect cells.
Background
The family of Parvoviridae is composed of small viruses that are non-enveloped and icosahedral. These viruses contain linear ssDNA (single-stranded DNA) genomes about 5000 nucleotides long. Canine parvovirus (CPV) belongs to Parvovirus genus of this family and fi rst appeared in the late 1970s, as a new disease. It is prevalent in dogs around the world (1, 2, 3) . CPV particles have a diameter of 25 nm and are composed of three proteins, VP1 (viral protein-1), VP2 (viral protein-2), and VP3 (viral protein-3) (4).
VP2 is the major component of the viral capsid. About 90% of the capsid protein is VP2, and 10% is VP1, which includes the entire sequence of VP2 and 154 additional residues at its N-terminus. The third protein (VP3) is generated after intracellular proteolytic cleavage of VP2
by removing approximately 25 amino acids from its N-terminus. Wild-type natural capsid is composed of 60 subunits primarily of the VP2, along with a few subunits of VP1 and VP3 (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . CPV has a natural affi nity to cancer cells via VP2 ligands/transferrin receptors (TfRs) attachment. In fact, the VP2 protein of CPV is the main part of attachment ligands for entry into specifi c and cancerous cells through transferrin receptors (TfRs) (1, 17, 18) . Yuan et al. (2001) claimed that VP2 can assemble into capsid-like structures and the expression of VP2 alone can result in assembly of a typically-sized virus like particle (VLP) for therapeutic purposes. VP2 protein of canine parvovirus binds to human cancer cells. Thus, it has the potential to be used as veterinary detection kit and for vaccine development (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . One of the best systems, considered in production of recombinant proteins, is the use of baculoviruses in insect cell expression system. The system allows proper post-translational modifi cations; producing biosimilars of protein of interest (19) (20) (21) (22) . Here, Bacto-Bac baculovirus expression vector system (BEVS) was used for heterologous expression in in insect cells. The system has two components: pFastBac donor plasmid vector into which the gene(s) of interest will be cloned and has an expression cassette and baculovirus shuttle vector (bacmid). In latter, the expression cassette is transposed via recombinant pFastBac (23).
Objectives
Our purpose was to construct recombinant bacmid shuttle vectors expressing GFP and VP2 of CPV using Bac-to-Bac baculoviral expression vector system (BEVS). The fi rst component of BEVS system through the construction of mini-Tn7 transposons was generated by cloning of GFP and CPV-VP2 genes into pFastBac1 donor plasmid vector. The second component of BEVS system was created through the construction of two recombinant bacmid DNAs, expressing GFP and VP2, using site-specifi c transposition mechanism. These constructs can be used to produce large scale of recombinant GFP and VP2 proteins in insect cells for therapeutic aims.
Materials and Methods

Preparation of the Genes, Plasmids, Bacterial Strains and Cells
The VP2 was isolated from the recombinant construct of pET-21a. The GFP was isolated from RAPAd® shRNA Adenoviral Expression System (Cell Biolabs, Inc). "T/A cloning vector" (RBC Bioscience, Taiwan) was used as the general vector. pFastBac1 was used as the transfer vector for subcloning , (Invitrogen, USA).
The E. coli strain DH5α (Invitrogen, USA) was used for transformation and amplifi cation of recombinant vectors (such as RBC T/A cloning vector and pFastBac1 donor plasmid vector). The E. coli strain DH10Bac (Invitrogen, USA) containing the modifi ed baculoviral DNA (bacmid shuttle vector) with a target site of miniattTn7 and the helper plasmid was used as a proper strain to carry out the transposition process. The helper plasmid begets tetracycline resistance and encodes the enzymes required for transposition of the gene of interest into the bacmid.
Spodoptera frugiperda (Sf9) cells were purchased from the Cell Bank (Iranian Biological Resource Center, Iran).
Extraction of the Plasmids
After the selection of proper colonies by blue/white screening, the recombinant plasmids were extracted from 1500 μL of bacterial cell cultures using a Roche commercial kit (Germany) according to the manufacturer's instructions.
Bacmid DNAs were isolated after the selection of proper colonies by blue/white screening of DH 10 Bac cells cultured on a LB agar plate (incubated at 37 ºC for 48 h) containing 7 μg.mL -1 gentamicin, 50 μg.mL -1 kanamycin, 10 μg.mL -1 tetracycline, 100 μg.mL -1 X-gal and 40 μg.mL -1 isopropylthio-β-D-galactoside or IPTG (Invitrogen, USA). The recombinant bacmid plasmids were also extracted from 1500 μL of bacterial broth cell cultures using a Roche commercial kit (Germany) according to the manufacturer's instructions. The bacmid DNA was isolated from overnight cultures by alkaline lysis method (24) .
It is notable that bacmid DNA is a high-molecularweight plasmid (~ 135 kbp) and due care to avoid shearing is to be taken.
Designing and Synthesizing the Specifi c Primers for CPV-VP2 and GFP Sequences
The sequences of VP2 region of CPV genome and GFP region were adapted from Genbank and the specifi c primers targeting these regions were designed using the Oligo software, version 3.0. The forward and reverse specifi c primers for VP2 and GFP are presented in Table 1 . The primer sequences did not show genomic cross-reactivity with other viruses, human genome and other probable interfering genomes in BLAST. It only detected a 1755 bp fragment of CPV-VP2 ORF and a 720 bp fragment of GFP ORF (data not presented). The primers were synthesized by Bioneer (Korea).
Isolation and Amplifi cation of CPV-VP2 and GFP
The full-lengths of CPV-VP2 (1755 bp) as well as GFP (720 bp) were PCR amplifi ed using specifi c primers and cloned into RBC T/A cloning vector. Template DNA (1 μL of each of the genes, separately) was added to a 50 μL total volume of PCR mixture containing 10 pmol of each forward and reverse primers, 5 mM MgSO 4 , 0.5 mM dNTPs, 2.5 U of pfu DNA polymerase (Fermentas, Vilnius, Lithuania) and 5 μL of 10× PCR buff er.
Amplifi cation reactions were performed in a thermocycler (Biorad, USA) under the following profi les: 5 min at 94 °C followed by 40 cycles at 94 °C for 45 sec, 67 °C for 60 sec and 72 °C for 160 sec, with a fi nal extension step at 72 °C for 10 min, for VP2 and 5 min at 94 °C followed by 40 cycles at 94 °C for 45 sec, 57 °C for 45 sec and 72 °C for 60 sec, with a fi nal extension
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step at 72 °C for 10 min, for GFP. PCR products were analyzed by electrophoresis using 1-2% (w/v) agarose gel, stained with safe view (Kiagene, IRI).
Cloning of VP2 and GFP into RBC T/A Cloning Vector
The PCR product was extracted from low melting agarose gel using a DNA extraction kit (VivantisKorea). The purifi ed amplicons were adenylated in a one-step procedure according to general protocols (24) . The adenylated amplicons were subsequently cloned into RBC T/A cloning vector (RBC Bioscience, Taiwan). Blue/ white screening allowed distinguishing colonies with plasmids containing the amplicon. The presence of inserts was checked by both PCR and enzyme restriction analysis (EcoRI/ XbaI).
Determination of the Orientation of the Genes
Gene orientation within cloning vector was determined by PCR using universal M13 forward (Invitrogen, USA), and specifi c forward and reverse primers. It is notable that the universal PUC/M13 fl anking sites are located in RBC vector (RBC Bioscience, Taiwan). BamHI/EcoRI restriction sites were chosen for subcloning of VP2 into pFastBac1 donor plasmid vector and EcoRI/XbaI restriction sites for GFP. The two genes were cloned in opposite directions.
Subcloning of VP2 and GFP into pFastBac1 Donor Plasmid Vectors
The VP2 and GFPwere digested with corresponding enzymes. The amplicons were gel-purifi ed using Vivantis DNA extraction kit (Korea). The purifi ed products were ligated into pFastBac1 donor plasmid vectors (Invitrogen, USA), digested using the same restriction enzymes.
The presence of the VP2 and GFP in expression cassette of pFastBac1 donor vectors containing miniTn 7 transposones were evaluated by DNA sequencing.
Construction of Two Individual Recombinant
Bacmid DNAs Encoding VP2 and GFP The VP2 and GFP containing recombinant pFastBac1 donor plasmids were transferred into the E. coli DH 10 Bac competent cells, separately. For site-specifi c transposition of VP2 or GFP into the bacmid shuttle vector, the cells containing the expression cassettes were incubated with transposing cassette for 4-6 h. The transposition causes the disruption of the lacZ operon. The presence of the helper plasmid that encodes the transposase is required. The transformed cells were cultured on a LB agar plate containing kanamycin (50 μg.mL -1 ), gentamicin (7 μg.mL -1 ), tetracycline (10 μg.mL -1 ), X-gal (100 μg.mL -1 ) and IPTG (40 μg.mL -1 ). The plates were incubated at 37 ºC for 16 h. The bacmid DNA was isolated from the overnight cultures by alkaline lysis purifi cation method. Hashemzadeh MS et al.
Analysis of Recombinant Bacmid DNAs
The transposition process accuracy and/or the existence of genes in bacmid DNAs were evaluated by PCR panel using both VP2 (or GFP) specifi c primers and PUC/M 13 universal primers (Table 1) . PCR using specifi c primers showed the accuracy of DH 10 Bac transformation by recombinant pFastBac1 and PCR using PUC/ M 13 universal primers. Orientations of the genes in recombinant bacmid were checked by PCR using VP2 (or GFP) specifi c and PUC/M 13 universal primers. 
Polymerase Chain Reaction
Cell Culture and Transfection of Sf9 Cells
Sf9 cells were grown in Grace's insect cell culture medium (Invitrogen, Catalog no. 11595-030) supplemented with 10% heat-inactivated fetal bovine serum or FBS (Gibco, USA), 1% non-essential amino acids and 2mM L-Glutamine (Bio-idea, Iran) and maintained in a non-humidifi ed incubator at 26-28 °C. For the highest transfection effi ciency, un-supplemented (no FBS) Grace's medium (pH 6.2-6.4) was used without antibiotics and serum.
To produce recombinant baculovirus, the precultured Sf9 cells (8 × 10 5 cells/well in 6-well tissue culture plates and in the log phase with greater than 95% viability and 70% confl uency) were transfect ed by 1-3 μg isolated recombinant bacmid DNA using a cationic lipid named Cellfectin II reagent (Invitrogen, USA) according to the manufacturer instruction. Cell density, DNA concentration, Cellfectin II concentration, DNA/ Cellfectin II ratio and incubation time were optimized. The transfected cells were incubated at 27 ± 0.5 ºC for 72 h to let baculovirus assembly and release into the culture medium. The recombinant baculovirus generation was monitored every day by visualization of the cytopathic eff ects (CPEs). The evaluated signs of infection included: a 25-50% increase in cell diameter, increased size of cell nuclei, cessation of cell growth, granular appearance, detachment from the plate or fl ask and cell lysis. The culture medium was collected 72 h post-infection (hpi), clarifi ed by low-speed centrifugation for 10 min at 1500 ×g and subjected to multiple rounds of virus propagation. These viral stocks were stored at +4 ºC in dark. FBS was added to a fi nal concentration of 2%.
Evaluation of VP2 Expression in Insect Cells
The infected cells were lysed with 100 μL of 1× SDS-PAGE buff er (62.5 mM Tris-HCl, pH 6.8, 2% w/v SDS) and boiled for at least 3 min after adding the sample buff er (10% w/v SDS, 10 mM 2-mercapto-ethanol, 20% v/v glycerol, 0.2 M Tris-HCl, pH 6.8, 0.05% w/v bromo-phenol-blue). The proteins in the samples were separated and examined by SDS-PAGE and Coomassie staining. Un infected Sf9 cells, which similarly treated were used as a negative control.
Evaluation of GFP Expression by Fluorescence Microscopy
The infected cells were monitored daily by visualization of green fl uorescent protein (GFP) expression using inverted fl uorescence microscope (Model no. CKX41; Olympus, Center Valley, PA, USA).
Results
Amplifi cation and cloning of CPV-VP2 and GFP
Gel-based analysis of amplifi ed VP2 and GFP fragments using the corresponding specifi c primers confi rmed the expected 1755 bp and 720 bp amplicons respectively, using 1-2% (w/v) agarose gel electrophoresis ( Supplementary Figs. 1a and 1b) .
The fragments were cloned into RBC T/A cloning vectors, separately after the extraction from low melting agarose gels and the accuracy of cloning process in these vectors were confi rmed using PCR ( Supplementary  Figs. 2a and 2c ) and enzymatic digestion analysis ( Supplementary Figs. 2b and 2d ).
Determination of VP2 & GFP Orientations in pFastBac1
The orientations of the genes in the cloning vectors determined by PCR panel using the universal PUC/M13 forward and specifi c forward primers, and the universal PUC/M13 forward and specifi c reverse primers, respectively. The fi rst PCR using the universal PUC/ M13 forward and specifi c forward primers was positive for VP2 and this was negative for GFP ( Supplementary  Figs. 3a and 3b) .
The fragments of VP2 and GFP, digested using the restriction sites of interest ( Supplementary Figs.  4a and 4d) were purifi ed (Supplementary Figure 4e) and subcloned into pFastBac1 donor plasmid vectors. Presence of the genes of interest in expression cassette of pFastBac1 was confi rmed by enzymatic digestion (Supplementary Figs. 4b, 4c and 4g ) and PCR ( Supplementary Figs. 4c and 4f) . Triple digestion using EcoRV and HindIII enzymes and also double digestion using BamHI and EcoRI were accomplished for VP2. Double digest was carried out using EcoRI and XbaI for GFP and the fragments produced were analyzed and confi rmed according to NEBcutter software pattern. Finally, the accuracy of the VP2 (or GFP) ORF in recombinant pFastBac1 was confi rmed by DNA sequencing . The orientation of the genes of interest was opposite and due to the orientations obtained, we chose BamHI/EcoRI restriction sites for subcloning of VP2 into pFastBac1 donor plasmid vector and EcoRI/ XbaI for GFP.
Analysis of Recombinant bacmid DNA Shuttle
Vectors for VP2 and GFP The transformation of E. coli DH 10 Bac cells was accomplished successfully by VP2 and GFP containing recombinant pFastBac1 donor plasmid vectors. The site-specifi c transposition of VP2 (or GFP) expression cassettes from the transposing vectors into the bacmid shuttle vectors were performed with the presence of helper plasmid and selected on LB agar. PCR was performed using PUC/M 13 universal primers to ensure the occurrence of ( Supplementary Figs. 5a and 5b) .
A PCR was carried out using VP2 (or GFP) specifi c and PUC/M 13 universal primers to ensure the transposition in recombinant bacmids. The bacmid DNA includes PUC/M 13 forward and reverse priming sites, fl anking the Tn 7 mini-att site within the region of LacZ α-complementation. The results indicated the accuracy of recombination through site-specifi c transposition mechanism and proper orientation of VP2 (or GFP) in the recombinant bacmid. The panel of PCR was performed using PUC/M 13 universal forward and reverse primers, VP2 (or GFP) gene specifi c forward and reverse primers, VP2 (or GFP) gene specifi c forward primer and PUC/M 13 universal reverse primer and fi nally VP2 (or GFP) gene specifi c reverse primer and PUC/M 13 universal forward primer, respectively( Supplementary Figs. 6a and 6b) .
Transfection of Sf9 Cells and CPE Observation
The extracted recombinant bacmid DNAs were transfect ed into Sf9 cells using Cellfectin II reagent (Invitrogen, USA) and untransfected Sf9 cul ture (as the negative control) continued to divide and formed a confl uent normal cell monolayer, quite diff erent from the infected cells (Figs. 1a and 1b) .
Expression of Recombinant VP2 in Insect Cells
Total proteins of the cell lysates were evaluated on 4-12% polyacrylamide gel (SDS-PAGE). In Figure  2a , the intended protein band with predicted molecular weight of about 64 kDa was de tected, representing the recombinant VP2 expression.
Western analysis using anti-VP2 monoclonal antibodies (AbCam, USA) confi rmed the specifi city of the detected band and also represented the expression accuracy of the protein of interest (Fig. 2b) . 
GFP Expression in Insect Cells by Fluorescence Microscopy
The results of fl uorescence microscopy showed successful expression of green fl uorescent protein (GFP) in insect cells (Fig. 3) .
Discussion
Bac-to-Bac baculoviral expression vector system (BEVS) is an effi cient and fast method to produce recombinant baculoviruses (23, (25) (26) .
Expression of recombinant genes in pFastBac vector is under the control of either polyhedrin (pH) or p10 promoter for high level expression in insect cell lines. The fl anking sites of the expression cassette (that contains the inserted gene) in the pFastBac vector are the right and left arms of Tn7 (Tn7R and Tn7L), and also this cassette is containing a resistance gene (gentamicin) and a SV40 poly A signal that forms a mini Tn7 transposon (23, (25) (26) .
The DH10Bac E. coli strain is being used as the host for recombinant pFastBac vector. This cells harbor a bacmid shuttle vector (derived from baculovirus) with a mini-attTn7 (attachment site for Tn7R and Tn7L) and a helper plasmid. After the construction of recombinant pFastBac, once this expression plasmid is transferred into DH10Bac cells, the transposition happens between the mini-attTn7 target site on the bacmid and the miniTn7 element on the pFastBac to produce a recombinant bacmid. The presence of transposition proteins encoded by the helper plasmid is necessary for this reaction. As soon as the transposition reaction is performed, one can extract the recombinant bacmid (with high molecular weight) and transfect it into the cultured insect cells to produce a new recombinant baculovirus. This generated virus can be used for primary expression evaluations. After the amplifi cation and titeration of the baculoviral stock, the produced high-titer seed can be used for infection of the insect cells and expression of the recombinant protein of interest in large scale (23, (27) (28) (29) (30) (31) (32) (33) .
Generation of recombinant baculovirus using Bac-toBac baculoviral expression system has some advantages over the traditional method that works on the basis of homologous recombination. The Bac-to-Bac requires less time to generate (2 weeks as opposed to 4-6 weeks), no need for plaque selection due to working based on blue/white selection, rapid and simultaneous isolation of several recombinant baculoviruses This method allows quick and simultaneous, and suitable for the expression of various proteins in structural and functional studies (23, (25) (26) . Considering these advantages, here Bacto-Bac baculoviral system was set up to express VP2 of canine parvovirus in large-scale in insect cells.
Conclusions
In this research, we designed two individual AcMNPV polyhedrin-plus Bac-to-Bac expression system in order to express GFP and CPV-VP2 in insect cells. The recombinant baculoviruses generated here were able to express recombinant VP2 protein (and GFP as the control) in Sf9 cells for the therapeutic aims.
